drugset / Trial / NCT01710670

A Study to Investigate the Drug-Drug Interactions of Brivaracetam and Ethanol in Healthy Male Subjects

NCT01710670

Phase 1 Completed 18 enrolled UCB Pharma
RandomizedCrossoverDouble-blindOther

Summary

To evaluate if Brivaracetam (BRV) influences the psychomotor and cognitive impairing effects of Ethanol

Timeline

Start
2012-09
Primary completion
2012-11
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Brivaracetam Small molecule 200 mg Oral

Indications

No indication recorded.